The racial and social justice challenges in 2020 had a profound impact on IMO’s leadership team. Our CEO, Ann Barnes, shares how we are navigating these issues to create an inclusive culture for our employees.
In creating not just one, but multiple, vaccines for the SARS-CoV-2 virus in under a year, pharmaceutical researchers and developers achieved a remarkable feat. But there’s still a challenge ahead: distributing and administering the vaccine across the country, while also managing a flood of inoculation data.
As vaccines for COVID-19 become more readily available, the possibility of getting back to life before the pandemic seems closer every day. That said, it’s still been over a year since the virus first appeared, requiring a slew of new terms and codes to describe not only the disease itself, but also adjacent tests, vaccines, and comorbidities. The following infographic shows how the industry and IMO responded to the clinical terminology needs of the past year.
